61 related articles for article (PubMed ID: 18177936)
41. NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair.
Bone KM; Wang P; Wu F; Wu C; Li L; Bacani JT; Andrew SE; Lai R
Blood Cancer J; 2015 May; 5(5):e311. PubMed ID: 25978431
[TBL] [Abstract][Full Text] [Related]
42. Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein.
Young LC; Bone KM; Wang P; Wu F; Adam BA; Hegazy S; Gelebart P; Holovati J; Li L; Andrew SE; Lai R
Am J Pathol; 2011 Jul; 179(1):411-21. PubMed ID: 21703420
[TBL] [Abstract][Full Text] [Related]
43. A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients.
Miyashita K; Fujii K; Taguchi K; Shimokawa M; Yoshida MA; Abe Y; Okamura J; Oda S; Uike N
J Cancer Res Clin Oncol; 2017 Mar; 143(3):399-408. PubMed ID: 27783137
[TBL] [Abstract][Full Text] [Related]
44. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
45. Azathioprine induction of tumors with microsatellite instability: risk evaluation using a mouse model.
Bodo S; Svrcek M; Sourrouille I; Cuillières-Dartigues P; Ledent T; Dumont S; Dinard L; Lafitte P; Capel C; Collura A; Buhard O; Wanherdrick K; Chalastanis A; Penard-Lacronique V; Fabiani B; Fléjou JF; Brousse N; Beaugerie L; Duval A; Muleris M
Oncotarget; 2015 Sep; 6(28):24969-77. PubMed ID: 26327213
[TBL] [Abstract][Full Text] [Related]
46. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability.
D'Errico M; de Rinaldis E; Blasi MF; Viti V; Falchetti M; Calcagnile A; Sera F; Saieva C; Ottini L; Palli D; Palombo F; Giuliani A; Dogliotti E
Eur J Cancer; 2009 Feb; 45(3):461-9. PubMed ID: 19081245
[TBL] [Abstract][Full Text] [Related]
47. [Clinical and molecular consequences of microsatellite instability in human cancers].
Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
[TBL] [Abstract][Full Text] [Related]
48. Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future.
Sorge CE; McDaniel JK; Xavier AC
Pharmaceuticals (Basel); 2016 May; 9(2):. PubMed ID: 27213405
[TBL] [Abstract][Full Text] [Related]
49. Frequent microsatellite instability in non-Hodgkin lymphomas irresponsive to chemotherapy.
Miyashita K; Fujii K; Yamada Y; Hattori H; Taguchi K; Yamanaka T; Yoshida MA; Okamura J; Oda S; Muta K; Nawata H; Takayanagi R; Uike N
Leuk Res; 2008 Aug; 32(8):1183-95. PubMed ID: 18177936
[TBL] [Abstract][Full Text] [Related]
50. High-resolution fluorescent analysis of microsatellite instability in gastric cancer.
Sakurai M; Zhao Y; Oki E; Kakeji Y; Oda S; Maehara Y
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):701-9. PubMed ID: 17625441
[TBL] [Abstract][Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
